A Phase 1 interventional study of Our Family Our Future in Sexual Behavior and Depression, sponsored by Brown University. Completed at 1 site in South Africa. Per ClinicalTrials.gov, last updated 2025-06-27.
Sponsored by Brown University · Phase 1, Interventional, and Prevention
The purpose of this study is to assess the feasibility and acceptability of a family-based preventive intervention designed to reduce sexual risk behaviors and depressive symptoms among South African adolescents and their parents/guardians/caregivers.
The Our Family Our Future Program is a preventive intervention program designed to prevent or reduce adolescent sexual risk behavior and to increase mental health resilience against depression onset among adolescents (13-15 years of age). The intervention takes a family approach and addresses HIV risk and depression in an integrated model. HIV and depression are the leading causes of global burden of disease in low and middle income countries. The intervention is being tested in South Africa, the country confronting the largest HIV epidemic in the world and because preliminary studies with South African families identified poor mental health and sexual risk behavior as priority areas for preventive intervention development and testing.
This study is a randomized pilot design, where 152 adolescents and parents will be randomly assigned to an intervention condition or a standard usual care condition and then offered the experimental intervention as on a wait-list. Families will be recruited and screened for eligibility based on systematic house-to-house recruitment in the community. Eligibility is based on dyadic eligibility and includes age criteria, consistent presence in the household, depressive symptoms that fall below clinically significant threshold criteria, and ability to provide informed consent and assent. Eligible families will be randomized and offered a preventive intervention program in a group format, led by program facilitators in a community setting. The intervention program consists of 3 sessions plus an individualized family meeting. In some modules parents/guardians/caregivers and adolescents will have content delivered together and in some modules parents/guardians/caregivers and adolescents will break out to adult-only or adolescent-only groups.
The overall objective of study is to assess the following study questions:
Question 1: Is this study feasible? Question 2: Is this intervention acceptable to the target population? Question 3: Is there preliminary evidence of hypothesized effects of the intervention, that the intervention will reduce or maintaining symptoms that fall below the clinically significant range for depression and reduce or delay actual or intended sexual risk behavior in adolescents?
The study takes a single blind, randomized pilot trial. The study takes a secondary prevention approach. The investigators collect three sets of data. First, the investigators assess feasibility by examining recruitment rates, attendance, completion, and drop-out rates, and fidelity. Second, the investigators assess acceptability by examining satisfaction data. Third, as a secondary aim, the investigators use pilot data to assess hypothesized intervention effects by examining outcomes at baseline, immediately post-intervention (2-4 weeks after the last intervention session is completed), and at four months.
224 studies on the registry are indexed under Sexual Behavior; 30 are open to participants now.
This study's enrollment of 146 is below the median of 264 across 179 interventional studies indexed under Sexual Behavior.
Browse Sexual Behavior studies →Brown University is the lead sponsor of 290 studies on the registry; 40 are open to participants now.
Of its 26 completed or terminated interventional studies of FDA-regulated products, 19 (73%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
PARENTS/GUARDIANS/CAREGIVERS
Adolescent inclusion criteria are:
Exclusion Criteria:
PARENTS/GUARDIANS/CAREGIVERS \& Adolescents
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Families are randomly allocated to a behavioral intervention arm (called Our Family Our Future) focusing on reducing sexual risk behavior in adolescents and reducing or maintaining symptoms that fall below the clinically significant range for depression. Arms will be allocated using urn randomization.
Behavioral: Our Family Our Future
Families are randomly allocated to the control arm (which receives standard usual care, and then offered the intervention after outcome assessments as a wait-list) using urn randomization.
The Our Family Our Future Program is a family preventive intervention that uses resilience and prevention focused strategies to reduce sexual risk behaviors and build mental wellbeing among adolescents.
Change from baseline in sexual behavior or intended sexual behavior at 4 months post-intervention
as measured through lifetime and past 3 month sexual acts, condom use, HIV and STI status, prior pregnancy
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change or maintenance of depressive symptoms at sub-clinical range from baseline to 4 months post-intervention measured by CES-D and CES-DC
Self-reported depressive symptoms
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Intervention acceptability - satisfaction with intervention content, delivery, length using the client satisfaction questionnaire and as measured on a likert scale response and as open-ended response options
Time frame: acceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
Intervention feasibility measured by attendance, retention for outcome assessments, fidelity
Time frame: cceptability will be assessed during the intervention, an expected average timeframe of 4 weeks
Change in resilience from baseline to 4 months post-intervention as measured through CD-RISC
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in depression impairment from baseline to 4 months post-intervention as measured through DISP and CPODMV
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in perceived HIV risk susceptibility from baseline to 4 months post-intervention using a ranking derived from a 0-100 and as measured on a likert scale response
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in HIV knowledge from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in HIV stigma from baseline to 4 months post-intervention as measured through the HIV Knowledge Questionnaire
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in norms and attitudes about sex from baseline to 4 months post-intervention as measured on a likert scale response
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in norms and attitudes about condoms from baseline to 4 months post-intervention as measured through the condom attitudes scale and likert response questions
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in sexual behavior self-efficacy from baseline to 4 months post-interventionusing a ranking derived from a 0-100 and as measured on a likert scale response
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in anxiety from baseline to 4 months post-interventionas measured through BAI and RCMAS
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in psychological distress from baseline to 4 months post-intervention as measured through K6 and SDQ
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in trauma symptoms from baseline to 4 months post-intervention as measured through PCL and NSESSS
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in substance use from baseline to 4 months post-intervention as measured through AUDIT and DUDIT
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in hope from baseline to 4 months post-intervention as measured through BHS
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in social support from baseline to 4 months post-intervention as measured through MSPSS
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family relationship from baseline to 4 months post-intervention as measured through Family Relationship Scale
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Communication Scale
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family communication from baseline to 4 months post-intervention as measured through the Parent-adolescent Sex Communication Scale
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in family relationship from baseline to 4 months post-intervention as measured through the Inventory of Parent-peer Attachment
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in parenting from baseline to 4 months post-interventionas measured through the Parental Monitoring Questionnaire
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
Change in parenting from baseline to 4 months post-intervention as measured through the Parenting Scale
Time frame: assessed at baseline, starting within 2-4 weeks of intervention end, and 4 months post-intervention
The record gives a start of May 2015, a primary completion of Jul 2017 and a completion of Jul 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.